Differences in the neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients

Peptides

Volumn 17, Issue 3, 1996, Pages 359-362

  Nilsson, Carol ^a   Karlsson, Gösta ^a   Blennow, Kaj ^a   Heilig, Markus ^a,b   Ekman, Rolf ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Depression; HPLC; Human platelets; Neuropeptide Y; Peptide fragments; Radioimmunoassay

Indexed keywords

NEUROPEPTIDE Y;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALE; PLASMA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; THROMBOCYTE;

EID: 0029938835     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-9781(96)00013-7     Document Type: Article

References (27)

1. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, third edition, revised. Washington, DC: American Psychiatric Association; 1987:229-230.
2. Arranz, B. Neurobiological aspects of human aging and suicide. Thesis, Linköping University, Linköping, Sweden; 1994:1-192.
3. 2 receptor binding on blood platelets - a peripheral marker for depression? Life Sci. 41:2485-2492; 1987.
4. Eckert, A.; Gann, H.; Riemann, D.; Aldenhoff, J.; Muller, W. E. Platelet and lymphocyte free intracellular calcium in affective disorders. Eur. Arch. Psychiatry Clin. Neurosci. 243:235-239; 1994.
5. Ericsson, A.; Hemsen, A.; Lundberg, J. M.; Persson, H. Detection of neuropeptide Y-like immunoreactivity and messenger RNA in rat platelets: The effects of vinblastine, reserpine, and dexamethasone on NPY expression in blood cells. Exp. Cell Res. 192:604-611; 1991.
6. Ericsson, A.; Larhammar, D.; McIntyre, K. R.; Persson, H. A molecular genetic approach to the identification of genes expressed predominantly in the neuroendocrine and immune systems. Immunol. Rev. 100:261-277; 1987.
7. Fried, G.; Lundberg, J. M.; Theodorsson-Norheim, E. Subcellular storage and axonal transport of neuropeptide Y (NPY) in relation to catecholamines in the cat. Acta Physiol. Scand. 125:145-154; 1985.
8. 2 receptors by substituted and truncated neuropeptide Y analogs: Identification of signal epitopes. Eur. J. Pharmacol. 232:271-278; 1992.
9. Hamilton, M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6:278-296; 1967.
10. Hashimoto, H.; Onishi, H.; Koide, S.; Kai, T.; Katayama, M.; Yamagami, S. Neuropeptide Y concentration and peptide fraction in plasma of patients with major depression. Annu. Rep. Pharmacopsychiatr. Res. Found. 25:179-185; 1994.
11. Heilig, M.; Koob, G. F.; Ekman, R.; Britton, K. T. Corticotropin-releasing factor and neuropeptide Y: Role in emotional integration. Trends Neurosci. 17:80-85; 1994.
12. Irwin, M.; Brown, M.; Patterson, T.; Hauger, R.; Mascovich, A.; Grant, I. Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress. FASEB J. 5:3100-3107; 1991.
13. Kogner, P.; Ericsson, A.; Barbany, G.; Persson, H.; Theodorsson, E.; Björk, O. Neuropeptide Y (NPY) synthesis in lymphoblasts and increased plasma NPY in pediatric B-cell precursor leukemia. Blood 5:1324-1329; 1992.
14. Lundberg, J. M.; Terenius, L.; Hökfelt, T.; et al. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects on NPY on sympathetic function. Acta Physiol. Scand. 116:477-480; 1982.
15. Myers, A. K.; Farhat, M. Y.; Shen, G. H.; Debinski, W.; Wahlestedt, C.; Zukowska-Grojec, Z. Platelets as a source and site of action for neuropeptide Y. Ann. NY Acad. Sci. 611:408-411; 1990.
16. Myers, A. K.; Torres Duarte, A. P.; Zukowska-Grojec, Z. Immunoreactive neuropeptide Y (NPY) in plasma and platelets of rat and mouse strains and human volunteers. Regul. Pept. 47:239-245; 1993.
17. Nugent, D. F.; Dinan, T. G.; Leonard, B. E. Alteration by a plasma factor(s) of platelet aggregation in unmedicated unipolar depressed patients. J. Affect. Disord. 31:61-66; 1994.
18. Ogawa, T.; Kitamura, K.; Kawamoto, M.; Eto, T.; Tanaka, K. Increased immunoreactive neuropeptide Y in platelets of spontaneously hypertensive rats (SHR). Biochem. Biophys. Res. Commun. 165:1399-1405; 1989.
19. O'Hare, M. M. T.; Tenmoku, S.; Aakerlund, L.; Hilsted, L.; Johnsen, A.; Schwartz, T. W. Neuropeptide Y in guinea pig, rabbit, rat and man. Identical amino acid sequence and oxidation of methionine-17. Regul. Pept. 20:293-304; 1988.
20. Pernow, J.; Lundberg, J. M.; Kaijser, L.; et al. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin. Physiol.6:561-578; 1986.
21. Persson, H.; Ericsson, A.; Hemsen, A.; et al. Expression of neuropeptide tyrosine (NPY) messenger RNA and peptide in nonneuronal cells. In: Mutt, V., et al., eds. Neuropeptide Y. New York: Raven Press; 1989:43-50.
22. Smith, P. K.; Krohn, R. I.; Hermansson, G. T.; et al. Measurement of protein using bicinchonic acid. Anal. Biochem. 150:76-85; 1985.
23. Tatemoto, K. Neuropeptide Y: Complete amino acid sequence of the brain peptide. Proc. Natl. Acad. Sci. USA 79:5485-5489; 1982.
24. Varndell, I. M.; Polak, J. M.; Allen, J. M.; Terenghi, G.; Bloom, S. R. Neuropeptide tyrosine (NPY) immunoreactivity in norepinephrine-containing cells and nerves of the mammalian adrenal gland. Endocrinology 114:1460-1462; 1984.
25. 2. Ann. NY Acad. Sci. 661:7-23; 1990.
26. Widerlöv, E.; Heilig, M.; Ekman, R.; Wahlestedt, C. Possible relationship between neuropeptide Y (NPY) and major depression -evidence from human and animal studies. Nord. Psykiatr. Tidsskr. 42:131-137; 1988.
27. Widerlöv, E.; Lindström, L. H.; Wahlestedt, C.; Ekman, R. Neuropeptide Y and peptide YY as possible cerebrospinal markers for major depression and schizophrenia, respectively. J. Psychiatr. Res. 22:69-79; 1988.